Skip to content

Clinical trials

Completed Phase 1/2 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1/2 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20061
20101
20171
20184
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vir Biotechnology, Inc.2
ANRS, Emerging Infectious Diseases1
Arrowhead Pharmaceuticals1
Barinthus Biotherapeutics1
Biotest Pharmaceuticals Corporation1
Columbia University1
Foundation for Liver Research1
Gilead Sciences1
Johns Hopkins Bloomberg School of Public Health1
Kiminori Kimura, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B14
Hepatitis B, Chronic3
HIV Infections2
Hepatitis2
Hepatitis C2
Bronchiolitis Obliterans Syndrome1
Carcinoma, Hepatocellular1
Hepatic Insufficiency1
Liver Cirrhosis1
Liver Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.